AAPL vs REGN · P/E 39, rev $416.16B vs P/E 14, rev $14.34B
Apple Inc (AAPL) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Tim Cook.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AAPL currently screens at market cap $3.83T and trailing P/E 39.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AAPL and REGN stock pages for the full models.
Not investment advice.